The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.
Roche prepares for business after boom from COVID-related products
Read Next
- GM reveals Corvette EV concept car as it reconfirms Europe commitment
- Elon Musk brother Kimbal says Trump tariffs permanent tax on consumers
- If you often use these 7 phrases, people see you as confident and trustworthy
- Auto sales are on a ‘roller coaster ride’ as tariffs take effect
- DB Investing hires AUS Global exec Gad Elkareem to head BizDev
- Recession fears hit Starbucks, Chipotle, McDonald’s stocks
- Crypto in 2025: Regulations, Rollercoasters, and the Road Ahead
